Leerink Upgrades Innate Pharma S.A. (IPHA) to Outperform

August 11, 2026 6:11 AM EDT Send to a Friend
Leerink analyst Daina Graybosch upgraded Innate Pharma S.A. (NASDAQ: IPHA) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login